Stephen J Hoffman's Net Worth
$2.31 Million
Who is Stephen J Hoffman?
Stephen J Hoffman has an estimated net worth of $2.31 Million. This is based on reported shares across multiple companies, which include Dicerna Pharmaceuticals Inc, Sirtris Pharmaceuticals, Inc., TETRAPHASE PHARMACEUTICALS INC, Aerpio Pharmaceuticals, Inc., Research Alliance Corp. II, GENOCEA BIOSCIENCES, INC., TALPHERA, INC., and ALLOS THERAPEUTICS INC.
SEC CIK
Stephen J Hoffman's CIK is 0001190418
Past Insider Trading and Trends
2010 was Stephen J Hoffman's most active year for acquiring shares with 7 total transactions. Stephen J Hoffman's most active month to acquire stocks was the month of May. 2010 was Stephen J Hoffman's most active year for disposing of shares, totalling 12 transactions. Stephen J Hoffman's most active month to dispose stocks was the month of December. 2017 saw Stephen J Hoffman paying a total of $3,223,066.00 for 611,012 shares, this is the most they've acquired in one year. In 2021 Stephen J Hoffman cashed out on 197,823 shares for a total of $618,005.25, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Dicerna Pharmaceuticals Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -16.16K |
$38.25 | -$618,005.25 |
0
|
Dec 28
| |||
Form 4
| +12.95% | 3.33K |
—
|
—
| 29.07K |
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 16
| |||
Form 4
|
∞
| 1.73M |
$15.00 |
—
| 1.73M |
Feb 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Sirtris Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.85M |
—
|
—
| 1.85M |
May 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
TETRAPHASE PHARMACEUTICALS INC No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -13.49% | -295.51K |
—
|
—
| 1.89M |
Mar 12
| |||
No matching records found |
Aerpio Pharmaceuticals, Inc. (AADI) Snapshot price: $1.82
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
∞
| 31.97K |
$2.01 | $64,135.65 | 31.97K |
Nov 9 - Nov 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Research Alliance Corp. II No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |